ResMed Director Peter Farrell Sells $227.7K in Stock via Rule 10b5-1 Plan
RESMED INC
Subscribe to track RMD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📋 ResMed Inc. ($RMD) - Insider Sale Insider: Peter C. Farrell (Director / Chairman Emeritus) Transaction: Sold 970 shares @ $234.73 ($227,688.10) Ownership After: 51,803 shares (Direct) Plan: Rule 10b5-1 plan adopted August 12, 2025 Filing Date: September 4, 2026
Comprehensive Analysis
Insider Transaction Summary
- Reporting Owner: Peter C. Farrell, Director & Chairman Emeritus
- Issuer: ResMed Inc. ($RMD)
- Transaction Date: September 2, 2026
- Transaction Type: Open market sale (Code:
S) - Shares Sold: 970 shares at an average price of $234.73 per share
- Total Transaction Value: $227,688.10
- Post-Transaction Holdings: 51,803 shares held directly
Notable Highlights
- Rule 10b5-1 Trading Plan: The transaction was executed pursuant to a pre-arranged Rule 10b5-1 trading plan adopted on August 12, 2025.
- Significance: Low. The sale represents approximately 1.8% of the insider's direct holdings prior to the transaction and was conducted under an established trading plan.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.
The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.
Always do your own due diligence and consult a licensed professional.